Risks to Production, Sales and Operating Performance from the Spread of COVID-19
First written in FY2020. 10 of 13 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2026RestatedAnnual report
「Although the group has implemented infection prevention measures for infectious diseases, if an infectious disease occurs and spreads at the sites of the group or its business partners, including sales destinations and upstream and downstream subcontracting factories,」
The company continued to disclose the risk of manufacturing and sales disruptions caused by the outbreak and spread of infectious diseases generally, rather than limited to COVID-19, together with the response through infection prevention measures. - FY2025ReframedAnnual report
「Although the group has implemented infection prevention measures for infectious diseases, if an infectious disease occurs and spreads at the sites of the group or its business partners, including sales destinations and upstream and downstream subcontracting factories,」
The wording has been broadened from a description limited to COVID-19 to the risk of manufacturing and sales disruptions caused by the outbreak and spread of infectious diseases generally. - FY2024-Q1MitigatedAnnual report
「During the three months ended the first quarter, restrictions on activity related to COVID-19 were eased and economic activity was returning to normal, while」
The company describes the easing of restrictions on activity related to COVID-19 and the normalization of economic activity. It also states that there were no new risks or material changes to business and other risks. - FY2023-Q3RestatedAnnual report
「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
No material changes are reported in the business and other risks described in the previous fiscal year, including COVID-19. - FY2023-Q1RestatedAnnual report
「During the three months ended the first quarter, the global economy continued to be affected by China's lockdowns due to the spread of COVID-19, the impact of monetary tightening by countries seeking to contain inflation, the situation in Ukraine, and the resulting surge in global resource prices,」
While the company describes the impact of the business environment, including China's lockdowns due to COVID-19, it states that there were no material changes to the business and other risks. - FY2022-Q3RestatedAnnual report
「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
No material changes are reported in the business and other risks described in the previous fiscal year, including COVID-19. - FY2022-Q2RestatedAnnual report
「During the six months ended the second quarter, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there were no material changes to the risks described for the previous fiscal year, including COVID-19. - FY2022-Q1RestatedAnnual report
「In some Asian countries, the delayed rollout of vaccines has made it difficult to contain the spread of infection, and considerable uncertainty remains regarding the outlook.」
Regarding the impact of COVID-19, the company states that although some regions continue to face difficulty containing the spread of infection, there were no material changes to the risks described for the previous fiscal year. - FY2021RestatedAnnual report
「Although the impact of the spread of COVID-19 on the business during the current consolidated fiscal year was limited, the company has faced certain constraints on business activities following the government's declaration of a state of emergency, including the implementation of thorough measures such as telework and staggered working hours to prevent infection among employees,」
While the impact on business during the fiscal year was limited, the company continues to remain alert to business constraints caused by infectious diseases and their potential future impact. - FY2021-Q3RestatedAnnual report
「During the nine months ended the third quarter, there were no material changes to the assumptions described in the annual securities report for the previous consolidated fiscal year, including assumptions concerning the future spread and timing of containment of COVID-19.」
The company states that there were no material changes to the previous fiscal year's assumptions concerning the impact of COVID-19. - FY2021-Q2RestatedAnnual report
「During the six months ended the second quarter, there were no material changes to the assumptions described in the annual securities report for the previous consolidated fiscal year, including assumptions concerning the future spread and timing of containment of COVID-19.」
The company states that there were no material changes to the previous fiscal year's assumptions concerning the impact of COVID-19. - FY2021-Q1RestatedAnnual report
「During the three months ended the first quarter, there were no material changes to the assumptions described in the annual securities report for the previous consolidated fiscal year, including assumptions concerning the future spread and timing of containment of COVID-19.」
The company states that there were no material changes to the previous fiscal year's assumptions concerning the impact of COVID-19. While the slowdown in the global economy continued, the impact on first-quarter results improved from the same period of the previous fiscal year. - FY2020First statedAnnual report
「To date, the impact of the spread of COVID-19 on the production and sales activities of the group has been limited. However, if the global slowdown in economic activity resulting from lockdowns and requests to refrain from going out continues for an extended period, it may adversely affect the group's business performance and financial condition going forward.」
The global spread of COVID-19 is described as a standalone risk for the first time. Although the current impact on production and sales is described as limited, the consolidated earnings forecast for the fiscal year ending March 2021 remains undetermined.